PetMed Express, Inc. (NASDAQ:PETS) is now up 11.75% compared to a 12-month low of $20.25. We have seen the price to move -3.41% lower and get settled at $22.63 on 4/12/2019. At recent session, it appeared stuck in a range of $22.57 to $23.84. This company shares are 3.09% off its target price of $23.33 and the current market capitalization stands at $465.95M. The recent change has given its price a 0.57% lead over SMA 50 and -51.68% deficit over its 52-week high. The stock witnessed 8.28% gains, 1.48% gains and -22.82% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found PETS’s volatility during a week at 3.15% and during a month it has been found around 3.14%.

PetMed Express, Inc. (PETS) Top Holders

Institutional investors currently hold around $484 million or 0% in PETS stock. Look at its top three institutional owners: Blackrock Inc. owns $69.61 million in PetMed Express, Inc., which represents roughly 14.94% of the company’s market cap and approximately 14.38% of the institutional ownership. Similar statistics are true for the second largest owner, Renaissance Technologies Llc, which owns 1,784,615 shares of the stock are valued at $40.39 million. The third largest holder is Vanguard Group Inc, which currently holds $31.27 million worth of this stock and that ownership represents nearly 6.71% of its market capitalization.

PetMed Express, Inc. 13F Filings

At the end of December reporting period, 102 institutional holders increased their position in PetMed Express, Inc. (NASDAQ:PETS) by some 4,782,815 shares, 100 decreased positions by 3,211,363 and 32 held positions by 13,413,694. That puts total institutional holdings at 21,407,872 shares, according to SEC filings. The stock grabbed 38 new institutional investments totaling 2,018,244 shares while 43 institutional investors sold out their entire positions totaling 1,363,083 shares.

PetMed Express, Inc. (NASDAQ:PETS) Insider Trades

Multiple company employees have indulged in significant insider trading. PetMed Express, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director SCHWEITZER ROBERT C has sold 7,500 shares of PetMed Express, Inc. (PETS) in the trading session dated Sep. 13, 2018. These shares are worth $277,500 and were traded at $37 each. The SEC filing shows that FORMICA FRANK J performed a sale of 5,000 shares. The Director disposed these shares by way of transaction on Jun. 12, 2018. The company’s shares were given away at $41.78 per share worth to an income of some $208,900 to the account of FORMICA FRANK J.

Director, KORN RONALD J, sold 5,000 common shares of PetMed Express, Inc. (PETS) in the open market. In a transaction dated Jan. 29, 2018, the shares were put up for sale at an average price of $48.38, raking in a sum of $241,900. After this sale, 68,833 common shares of PETS are directly owned by the insider, with total stake valued at $1,557,691.

In the transaction dated Jan. 22, 2018, a great number of shares sold came courtesy the CEO & President; AKDAG MENDERES disposed a total of 10,000 shares at an average price of $57, amounting to approximately $570,000. The insider now directly owns 470,000 shares worth $10,636,100.

PetMed Express, Inc. (PETS) Analyst Guide

Several analysts have released their opinion on PetMed Express, Inc. (NASDAQ:PETS), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 2 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation [T1].